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Lipid oxidation has been implicated in the pathogenesis of many diseases. Lipids are oxidized in vivo by
several different oxidants to give diverse products, in general lipid hydroperoxides as the major primary
product. In the present study, the production of lipid hydroperoxides in the oxidation of mouse plasma
induced by multiple oxidants was measured using diphenyl-1-pyrenylphosphine (DPPP) as a probe. DPPP
itself is not ﬂuorescent, but it reacts with lipid hydroperoxides stochiometrically to give highly ﬂuor-
escent DPPP oxide and lipid hydroxides. The production of lipid hydroperoxides could be followed
continuously in the oxidation of plasma induced by peroxynitrite, hypochlorite, 15-lipoxygenase, and
peroxyl radicals with a microplate reader. A clear lag phase was observed in the plasma oxidation
mediated by aqueous peroxyl radicals and peroxynitrite, but not in the oxidation induced by hypochlorite
and lipoxygenase. The effects of several antioxidants against lipid oxidation induced by the above oxi-
dants were assessed. The efﬁcacy of antioxidants was dependent markedly on the type of oxidants. α-
Tocopherol exerted potent antioxidant effects against peroxyl radical-mediated lipid peroxidation, but it
did not inhibit lipid oxidation induced by peroxynitrite, hypochlorite, and 15-lipoxygenase efﬁciently,
suggesting that multiple antioxidants with different selectivities are required for the inhibition of plasma
lipid oxidation in vivo. This is a novel, simple and most high throughput method to follow plasma lipid
oxidation induced by different oxidants and also to assess the antioxidant effects in biologically relevant
settings.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lipid oxidation proceeding inevitably in vivo gives rise to de-
leterious effects such as functional loss of biological membranes,
protein modiﬁcation, enzyme deactivation, and nucleic acid da-
mage, which has been implicated in the pathogenesis of various
diseases [1,2]. Lipids are oxidized in vivo by multiple oxidants.
Among them, peroxynitrite, hypochlorite, lipoxygenases, cycloox-
ygenase, cytochrome P450, and singlet oxygen have been shown
to induce lipid oxidation to give diverse products [3,4]. In the free
radical mediated lipid peroxidation, peroxyl radicals act as chainB.V. This is an open access article u
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ar Gastroenterology and He-
oto 602-8566, Japan.carrying species independent of the type of initiating radical
species to produce lipid hydroperoxides as primary major pro-
ducts, while non-radical oxidants oxidize lipids to give other
speciﬁc products.
Peroxynitrite is one of the major reactive oxidants and nitrating
species [5,6]. Neither superoxide nor nitric oxide is reactive en-
ough per se to induce lipid oxidation, but they react with each
other rapidly to give peroxynitrite. It was reported that perox-
ynitrite or simultaneous production of nitric oxide and superoxide
induces plasma oxidation to produce malonaldehyde and con-
jugated diene [7], cholesteryl ester hydroperoxide [8,9] and F2-
isoprostanes [10]. It has been reported also that peroxynitrite in-
duces lipid peroxidation of LDL [11,12]. The formation of phos-
phatidylcholine and phosphatidylethanolamine hydroperoxides
was observed in the oxidation of erythrocytes by peroxynitrite
[13].
Lipoxygenases oxidize polyunsaturated fatty acids to produce
regio-, stereo-, and enantio-speciﬁc hydroperoxides by non-radical
mechanisms [14]. Rabbit reticulocyte 15-lipoxygenase was foundnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tidylcholine hydroperoxides speciﬁcally [15].
Hypochlorous acid (HOCl) produced in stimulated neutrophils
via the myeloperoxidase (MPO) catalyzed reaction of hydrogen
peroxide with Cl is a reactive oxidant [16,17] and it oxidizes
unsaturated fatty acids and cholesterol to produce chlorohydrins
[18]. Hypochlorite reacts with amines to produce choloramines,
which undergo decomposition to give carbon- and nitrogen-cen-
tered radicals. It also reacts with hydrogen peroxide to produce
singlet oxygen, while it reacts with lipid hydroperoxides to give
alkoxyl/peroxyl radicals [19]. Singlet oxygen also gives hydroper-
oxides from unsaturated fatty acids, cholesterol, and their esters as
primary products. On the other hand, cyclooxygenase, cytochrome
P450, and ozone do not produce lipid hydroperoxides.
With increasing evidence showing the involvement of oxida-
tive modiﬁcation of biological molecules in the pathogenesis of
various diseases, the role and effects of antioxidants have received
much attention, but recent large scale human intervention studies
gave disappointing and inconsistent results [20]. Giving large do-
ses of dietary antioxidant supplements to human subjects has, in
most studies, demonstrated little or no preventive or therapeutic
effect. Such “antioxidant paradox” has been the subject of ex-
tensive arguments [21].
It must be noteworthy that, as stated above, lipids are oxidized
in vivo by multiple oxidants and the effects of antioxidants depend
on the oxidants. The inconsistent and conﬂicting results of human
trials on vitamin E, the most widely studied biological antioxidant,
may be, at least in part, due to the facts that multiple oxidants are
involved in the oxidative damage, while vitamin E is effective
against only free radical mediated mechanisms, but not against
non-radical mechanisms [22]. It is therefore imperative to specify
the reactive oxidants and measure the effects of antioxidants
against different oxidants.
Many kinds of methods have been developed to measure lipid
oxidation products. The recent advancement of mass spectro-
metric analysis enabled to identify and measure numerous kinds
of oxidation products in their intact forms [4]. However, lipid
oxidation in vivo gives diverse products with many positional and
stereo isomers, making it practically quite difﬁcult to measure all
of them, while it is also necessary to measure total lipid oxidation
for assessment of, for example, oxidative stress status or screening
of effective antioxidants.
In the present study, the production of lipid hydroperoxides
was measured in the oxidation of plasma induced by several oxi-
dants using diphenyl-1-pyrenylphosphine (DPPP) as a probe. DPPP
itself is not ﬂuorescent, but it reacts with lipid hydroperoxides
stoichiometrically to give the corresponding lipid hydroxides and
DPPP oxide, which is strongly ﬂuorescent. By virtue of this prop-
erty, DPPP has been used in the measurement and analysis of lipid
hydroperoxides in biological samples [23–28]. The formation of
lipid hydroperoxides in the cultured cells under oxidative stress
has been measured also by DPPP [29–33]. The uptake of oxidized
LDL containing DPPP oxide into macrophages has been analyzed
[34]. This was applied also for the assessment of antioxidant ac-
tivity against lipid peroxidation [33,35–38]. It was reported that
the DPPP method was amenable for high-throughput screening to
the inhibitor of lipoxygenase reaction [39]. Recently, we reported
the production of lipid hydroperoxides in the oxidation of plasma
induced by singlet oxygen and its inhibition by antioxidants as
assessed by DPPP [40]. In this study, peroxyl radicals, peroxyni-
trite, 15-lipoxygenase, and hypochlorite were chosen as biological
oxidant which produces lipid hydroperoxides.2. Materials and methods
2.1. Materials
2,2′-Azobis(2-amidinopropane) dihydrochloride (AAPH) and
2,2′-azobis-(4-methoxy-2,4-dimethyllvaleronitrile) (MeO-AMVN),
used as water-soluble and lipid-soluble radical initiator respec-
tively, were obtained from Wako Pure Chemical Industries Ltd.,
Japan. Peroxynitrite was generated by simultaneous formation of
superoxide and nitric oxide from 3-morpholinosydnonimine (SIN-
1) [11], which was obtained from DOJINDO Laboratories, Japan.
DPPP and 2-carboxy-2,5,7,8-tetramethyl-6-hydroxychroman (Tro-
lox) were purchased from Cayman Chemical Company (Michigan,
USA). Sodium hypochlorite, nordihydroguaiaretic acid (NDGA),
and baicalein were obtained from WAKO Pure Chemical Industries
Ltd., Japan. Rabbit reticulocytes 15-lipoxygenase was purchased
from Enzo Life Science Inc. (New York, USA). Caffeic acid was ob-
tained from Nakalai Tesque Co., Japan. Other chemicals were those
of the highest grade available commercially.
Wild type male C57BL/6J mice purchased from Shimizu Labora-
tory Supplies Co. Ltd., Japan were maintained under standardized
conditions of 12-h/12-h light/dark schedule. Blood was collected in
heparin-containing tubes from mice. Plasma was obtained by cen-
trifugation at 3500 rpm for 15 min at 4 °C and frozen on ice im-
mediately and stored until use as reported previously [41]. The ani-
mal experiments and care were approved by the Institutional Animal
Care and Use Committee of Kyoto Prefectural University of Medicine.
2.2. Measurement of lipid hydroperoxides
Plasma (10 vol%, unless otherwise speciﬁed) was oxidized with
multiple oxidants at 37 °C in PBS (pH 7.4) under air in the absence
and presence of antioxidant. Lipid hydroperoxides was measured
from the ﬂuorescence intensity by DPPP oxide, the excitation and
emission wavelength being 351 and 380 nm respectively, with a
microplate reader, Spectra Max M2 (Molecular Devices, Sunnyvale,
CA) equipped with a thermostatted cell maintained at 37 °C under
air as reported previously [41]. The oxidation was started by the
addition of the respective oxidant into the PBS solution of plasma
in the presence of DPPP and additives. DPPP and antioxidants were
added as DMSO solution. The concentration of DMSO was kept to
or less than 2.5 vol%.
Since the plasma obtained from different mice contained dif-
ferent composition of lipids and antioxidants, the same plasma
was used for a set of experiments. The experiments were repeated
at least twice, in most cases more than three times, and the re-
producibility was satisfactory.3. Results
3.1. Plasma lipid oxidation induced by peroxyl radicals, peroxynitrite,
hypochlorite, and 15-lipoxygenase
The production of lipid hydroperoxides was followed con-
tinuously in the oxidation of mouse plasma induced by multiple
oxidants by an increase in ﬂuorescence intensity (FI) due to DPPP
oxide formed by the reaction of DPPP and lipid hydroperoxides.
AAPH, MeO-AMVN, SIN-1, hypochlorite, and 15-lipoxygenase all
induced lipid hydroperoxide production as shown in Fig. 1A. The
concentration dependence on MeO-AMVN, SIN-1, and 15-lipox-
ygenase is shown in Fig. 1B–D, respectively. It may be noteworthy
that a lag phase was observed before rapid increase in FI in the
oxidation induced by AAPH and SIN-1, but not in the oxidation
induced by MeO-AMVN, lipoxygenase, and hypochlorite. This may
be because hydrophilic endogenous antioxidants in plasma such as
Fig. 1. Production of lipid hydroperoxides in the plasma oxidation induced by multiple oxidants. (A) Accumulation of lipid hydroperoxides in the oxidation of mouse plasma
at 37 °C induced by AAPH (100 mM), MeO-AMVN (1 mM), SIN-1 (0.1 mM), 15-lipoxygenase (1000nkat), and sodium hypochlorite (1 mM) was measured by an increase in
ﬂuorescence intensity due to DPPP oxide as described in Section 2. (B), (C), (D) Effects of concentrations of MeO-AMVN, SIN-1, and 15-lipoxygenase, respectively. Numbers in
the ﬁgures B and C show the concentration in mM, while D the concentration in nkat.
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radicals produced in the aqueous phase, whereas the oxidation
induced by lipoxygenase and hypochlorite was not inhibited by
endogenous antioxidants in plasma. Hydroperoxides formed by
the peroxyl radicals derived from MeO-AMVN may account for
some of FI. Concentration of DPPP was changed from 0 to 150 μM.
The FI increased with an increase in DPPP concentration, but
reached almost plateau at 100 μM (data not shown). Therefore, the
oxidation was performed with 100 μM DPPP.
AAPH and MeO-AMVN decompose thermally to produce car-
bon-centered radicals, which react rapidly with oxygen to give
peroxyl radicals [42,43]. The peroxyl radicals thus formed attack
plasma lipids to induce chain reaction of lipid peroxidation
yielding cholesteryl ester hydroperoxides and phosphatidylcholine
hydroperoxides as major products [44,45]. The effects of AAPH and
plasma concentrations were studied (Fig. 2). The lag phase was
directly proportional to 1/[AAPH] and plasma concentration
(Fig. 2B and D). Similarly, MeO-AMVN, a lipid soluble azo initiator
which produces peroxyl radicals in lipophilic domain [42], induced
plasma lipid peroxidation giving rise to an increase in FI in a
concentration dependent manner (Fig. 1B). It may be noted that
the reaction of peroxyl radicals derived from MeO-AMVN with
antioxidant or polyunsaturated lipids produce hydroperoxides,
which react with DPPP to give DPPP oxide.Furthermore, SIN-1 induced lipid oxidation and increased FI in
a concentration dependent manner (Fig. 1C). SIN-1 decomposes
thermally to give superoxide and nitric oxide, which react rapidly
to yield peroxynitrite, ONOO-, the rate constant being
1010 M1s1. It may be present also as peroxynitrous acid,
ONOOH, the pKa being 6.8 [6]. At the physiological pH of 7.4,
peroxynitrite anion will be present in proportion of 80%. Perox-
ynitrous acid decomposes homolytically to hydroxyl radical and
nitrogen dioxide radical. Peroxynitrite reacts with carbon dioxide,
the rate constant being 4.6104 M1s1, to give a nitrosoperox-
ocarboxylate adduct (ONOOCO2-) that undergoes a fast homolysis
to ●NO2 radical and carbonate radical anion ( ●−CO3 ) in 34% yields,
with the remaining yielding carbon dioxide and nitrate, −NO3
[5,6,46]. Thus, peroxynitirte may give several reactive oxidants and
induce lipid oxidation.
15-Lipoxygenase also induced oxidation of plasma lipids
without lag phase and a concentration dependent increase in FI
was observed (Fig. 1D). It has been reported that rabbit re-
ticulocytes 15-lipoxygenase oxidizes plasma to give phosphati-
dylcholine and cholesterol ester hydroperoxides regio-, stereo-,
and enantio-speciﬁcally [14,15].
Hypochlorite similarly induced lipid oxidation in plasma to
produce lipid hydroperoxides (Fig. 1A). It was reported that pro-
teins were major target of hypochlorite in plasma [47], but it also
Fig. 2. The concentration dependence of plasma lipid oxidation on (A) AAPH and (C) plasma. Plasma was oxidized at 37 °C and an increase in ﬂuorescence intensity was
measured as described in Section 2. The numbers in A and C are concentrations of AAPH and plasma in mM and %, respectively. The concentrations of plasma and AAPH in A
and C are 10% and 100 mM, respectively. (B), (D) Plot of lag phase against 1/[AAPH] and plasma concentration respectively.
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isms [16,17]. The free radical derived from chloramines may in-
duce lipid peroxidation.
The plasma oxidation induced by AAPH was studied in some
more detail (Fig. 2A and B). The lag phase decreased with in-
creasing AAPH concentration, as expected in proportion to 1/
[AAPH], since lag phase is inversely proportional to the rate of free
radical ﬂux which is proportional to AAPH concentration. The ef-
fects of plasma concentration on the increase in FI are shown in
Fig. 2C. A clear lag phase was observed, which increased pro-
portionally with increasing plasma concentration (Fig. 2D). The
slope of the plot of lag phase against plasma concentration was
obtained as 29.5 s/%.
In Fig. 3 are shown the effects of plasma concentration on the
lipid oxidation induced by SIN-1. The lag phase increased with
increasing plasma concentration and the plot of lag phase as a
function of plasma concentration gave a straight line with a slope
48 s/% and an intercept on Y-axis 300 s.
3.2. Effects of antioxidants against plasma lipid oxidation induced by
multiple oxidants
The effect of Trolox on the plasma oxidation induced by AAPH
is shown in Fig. 4A and B. The plot of lag phase produced by Trolox
against Trolox concentration gave a straight line: lag phase¼42.3
[Trolox]þ536 (Fig. 4B). The lag phase observed in the absence of
added Trolox, 536 s, is attributed to the endogenous antioxidants
in plasma. The lag phase is given by Eq. (1):
= [ ] ( )nLag phase Trolox /Ri 1The stoichiometric number, n, for Trolox is 2. The rate of free
radical ﬂux from AAPH, Ri, is calculated from the slope of the plot
shown in Fig. 4B: Ri¼2/slope. The average Ri with 100 mM AAPH
was obtained from the slope of three independent experiments as
4.7108 M/s. The concentration of endogenous antioxidants
which produced lag phase in the oxidation of plasma is then cal-
culated from the lag phase obtained from the results in Fig. 2D,
29.5 s/%, and the above Ri as n[antioxidant]¼ lag
phaseRi¼29.51024.7108¼1.4104 M, assuming n is
1.
The total concentration of antioxidants contained in plasma,
termed total antioxidant capacity (TAC), may be estimated from
the lag phase produced by plasma in the consumption of a probe
such as ﬂuorescein and pyranine induced by AAPH. It was esti-
mated in the previous study that the mouse plasma contained
9.74104 M antioxidants, more strictly speaking the plasma
could scavenge 9.74104 M peroxyl radicals [41]. This is about
7 times larger than the above value, 1.4104 M, estimated from
the lag phase observed in the oxidation plasma lipids. This dif-
ference is attributed to the fact that TAC estimated from the lag
phase produced by unreactive probe such as ﬂuorescein and pyr-
anine counts weak antioxidants as well which are not reactive
enough to scavenge peroxyl radicals in competition with biological
substrates to suppress plasma oxidation.
The effects of Trolox on the SIN-1 induced plasma oxidation
were also studied (Fig. 4C, D). Trolox increased lag phase and the
plot of lag phase against Trolox concentration gave a straight line
with a slope and Y-axis intercept 67.3 s/μM and 800 s, respectively.
The rate of free radical ﬂux from 0.5 mM SIN-1 under the present
reaction conditions is calculated as Ri¼n/slope¼2/67.3 μM/
s¼3.0108 M/s. With these Ri and Y-axis intercept, the
Fig. 3. Effects of plasma concentration on lipid oxidation induced by SIN-1. (A) Plasma (5–30 vol%) was oxidized with 0.5 mM SIN-1 in the presence of 100 μM DPPP and the
increase in ﬂuorescence intensity (FI) was followed as described in Section 2. Numbers in the Figure are plasma concentration in %. (B) Lag phase was plotted against plasma
concentration.
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lag phase in the SIN-1 induced plasma lipid oxidation is calculated
as n[IH]¼8003.0108¼2.4105 M, which is much smaller
than the above value 1.4104 M obtained from the lag phase
observed for oxidation induced by AAPH. This difference reﬂects
the different reactivities in the initiating species derived from
AAPH and SIN-1.
The antioxidant effects against lipid peroxidation induced by
azo-initiators have previously been studied in detail [44,45]. In the
present study, the effects of several antioxidants on the plasma
lipid oxidation induced by peroxynitrite, hypochlorite, and 15-li-
poxygenase were assessed.
The effects of α-tocopherol, γ-tocopherol, ascorbic acid, uric
acid, and Trolox on the plasma lipid oxidation induced by SIN-1
are shown in Fig. 5A. FI increased after a lag phase of around
1000 s independent of the presence or absence of addedantioxidant, which was produced by the endogenous antioxidant
in the plasma. The FI did not increase linearly with time in the
oxidation induced by SIN-1, which may be ascribed to complex
initiation mechanisms of lipid oxidation mediated by multiple
oxidants derived from SIN-1. Hydrophilic antioxidant such as as-
corbic acid, Trolox, and uric acid suppressed oxidation more sig-
niﬁcantly than lipophilic α-tocopherol and γ-tocopherol. As ob-
served previously [12], γ-tocopherol exhibited more potent anti-
oxidant effect than α-tocopherol against SIN-1 induced lipid oxi-
dation (Fig. 5C), which implies the contribution of ●NO2 radical.
However, considering much higher bioavailability and physiolo-
gical concentration of α-tocopherol than γ-tocopherol and the
difference between the two tocopherols shown in Fig. 5C, it may
be surmised that α-tocopherol exerts more potent effect than γ-
tocopherol in vivo against SIN-1 mediated plasma oxidation.
The effects of glutathione, bilirubin, baicalein, and fucoxanthin
Fig. 4. Effect of Trolox on the lipid oxidation of plasma induced by AAPH (A, B) and by SIN-1 (C, D). Plot of lag phase against Trolox concentration in the oxidation by AAPH
(B) and SIN-1 (D). Plasma (10%) was oxidized with 100 mM AAPH or 0.5 mM SIN-1 in the presence of 100 μM DPPP and added Trolox at 37 °C and an increase in ﬂuorescence
intensity (FI) was measured as described in the Section 2. The numbers in the Figures A and C are Trolox concentration in μM.
Fig. 5. Effect of antioxidants on the plasma oxidation induced by SIN-1. Plasma was oxidized with 0.5 mM SIN-1 in the presence of 100 μM DPPP and 50 μM (A) α-tocopherol,
γ-tocopherol, ascorbic acid, uric acid, (B) glutathione, bilirubin, baicalein, and fucoxanthin. (C) Plot of FI(þ IH)/FI(-IH) against α-tocopherol (black) and γ-tocopherol (red)
concentration.
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Fig. 6. Effect of antioxidant on the plasma oxidation induced by hypochlorite.
Plasma (10%) was oxidized by 0.5 mM NaOCl in the presence of 100 μM DPPP in the
absence and presence of α-tocopherol, fucoxanthin, baicalein (25 μM), or ascorbic
acid, uric acid, glutathione, and bilirubin (50 μM) and the production of lipid hy-
droperoxides was followed as described in the Section 2.
M. Morita et al. / Redox Biology 8 (2016) 127–135 133on the SIN-1 induced plasma oxidation are shown in Fig. 5B. They
suppressed the oxidation partially, but kinetic analysis is difﬁcult.
The results of antioxidant effects against plasma lipid oxidation
induced by hypochlorite are shown in Fig. 6. Among the antioxidants
tested, bilirubin and fucoxanthin inhibited lipid oxidation efﬁciently,
while α-tocopherol, ascorbic acid, uric acid, glutathione, and baica-
lein did not inhibit plasma oxidation signiﬁcantly. Recently it was
reported that bilirubin inhibited chloramine formation from hypo-
chlorite and inhibited myeloperoxidase-induced lipid oxidation [48].Fig. 7. Effect of antioxidant on the plasma oxidation induced by 15-lipoxygenase. (A) Eff
effect of NDGA and baicalein, respectively, on lipid hydroperoxide production. (D) Plot o
and caffeic acid(▲). Plasma (10%) oxidation was performed in the presence of 100 μM DNeither α-tocopherol nor Trolox exerted signiﬁcant antioxidant
effect against 15-LOX-induced plasma lipid oxidation, whereas
nordihydroguaiaretic acid (NDGA), baicalein, and caffeic acid in-
hibited oxidation efﬁciently in a concentration dependent manner
(Fig. 7), the IC50 being 2.8, 6.8, and 29 μM respectively.4. Discussion
The above results show that peroxynitrite, hypochlorite, 15-
LOX, as well as the peroxyl radicals produced by azo initiator all
induced plasma lipid oxidation to give lipid hydroperoxides. This is
a novel method using DPPP as a probe to follow the production of
lipid hydroperoxides in the oxidation of plasma induced by dif-
ferent kinds of oxidants and also to assess the antioxidants effects
of speciﬁc compounds and natural products.
Azo compound, although biologically irrelevant, generates
peroxyl radicals in the presence of oxygen at a constant rate and
controlled site, which is useful for kinetic study on the oxidation of
biological molecules and its inhibition [43]. The peroxyl radicals
derived from azo compounds and those formed in vivo physiolo-
gically and pathologically react with biological molecules similarly.
Peroxynitrite is one of the important oxidants produced in vivo
[5,49,50], which has been reported to induce plasma lipid oxidation
to produce cholesteryl ester hydroperoxides and phosphatidylcholine
hydroperoxides [8–12]. This study showed continuous accumulation
of plasma lipid hydroperoxides mediated by peroxynitrite and otherect of α-tocopherol, Trolox, NDGA, baicalein, and caffeic acid. (B), (C): Concentration
f hydroperoxides formed against antioxidant concentration: NDGA(●), baicalein(■),
PPP at 37 °C.
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and carbonate radical anion [5,6,49].
Hypochlorite is another important oxidants playing important
role especially at the site of inﬂammation. It has been reported
that proteins are major target in plasma for hypochlorite [47], but
this study clearly shows the production of lipid hydroperoxides in
the plasma oxidation by hypochlorite, although the relative im-
portance of lipid oxidation and protein oxidation is not clear and
the contribution of protein hydroperoxides in DPPP oxide forma-
tion cannot be ruled out. The characterization of lipid hydroper-
oxides produced by hypochlorite is a subject of future study.
The above results show that antioxidant effect against lipid
oxidation induced by different oxidants is assessed easily by the
present method using DPPP in biologically relevant system. It is
important to understand that multiple oxidants with different
reactivity and selectivity contribute to the oxidation of biological
molecules in vivo and that the efﬁcacy of antioxidants depends on
the type of oxidants. It has been shown that vitamin E and vitamin
C inhibit plasma lipid peroxidation quite efﬁciently [44,45], but the
effects of antioxidants against plasma oxidation by other oxidants
have not been studied as extensively.
Ascorbic acid exerted more potent antioxidant effect against
peroxynitrite induced oxidation than uric acid and bilirubin. γ-
Tocopherol suppressed lipid oxidation more than α-tocopherol
(Fig. 5) as reported previously [12]. γ-Tocopherol which is con-
tained in diets as much as α-tocopherol deserves more attention
[51], but much lower bioavailability than α-tocopherol should be
taken into consideration [33].
α-Tocopherol exerted poor antioxidant effect against 15-LOX
mediated oxidation, while NDGA, baicalein, and caffeic acid in-
hibited it in a concentration dependent manner. NDGA used an-
ciently in folk medicine for the treatment of multiple diseases is
known as lipoxygenase inhibitor [52] and showed most potent
inhibition among the antioxidant tested in this study. The in-
hibitory effect of baicalein against 12/15-LOX was reported pre-
viously [53].
Glutathione is one of the most important antioxidants in vivo,
working as an essential reducing agent with glutathione perox-
idases. In the present study, glutathione did not exert a potent
antioxidant effect against plasma lipid oxidation induced by per-
oxynitrite and hypochlorite, although glutathione has been re-
ported to scavenge hypochlorite rapidly with a rate constant
1.1108 M1 s1 [54] and it reacts with peroxynitrous acid by a
rate constant 7.3102 M1 s1 [55]. Glutathione scavenges per-
oxyl radical slower than ascorbic acid [56] and further the re-
sulting glutathione thiyl radical is not stable, making glutathione
less potent antioxidant against lipid oxidation.
Collectively, the method employed in the present study using
DPPP as a probe may be useful to follow plasma lipid oxidation
induced by multiple oxidants and also to assess the antioxidant
capacity in biologically relevant settings.Conﬂict of interest
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